^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    anti-CD19 DASH CAR-T

    i
    Other names: anti-CD19 DASH CAR-T
    Associations

    News

    Trials
    Company:
    Hrain Biotech
    Drug class:
    CD19-targeted CAR-T immunotherapy
    Related drugs:
    Associations

    News

    Trials
    2years
    To Evaluate the Safety and Efficacy of Human CD19 Targeted DASH CAR-T Cells Injection for Subjects With R/R B-ALL (clinicaltrials.gov)
    P1, N=9, Recruiting, Hrain Biotechnology Co., Ltd.
    New P1 trial • CAR T-Cell Therapy
    |
    CD19 (CD19 Molecule) • IL6 (Interleukin 6) • IL15 (Interleukin 15)
    |
    CD19 positive
    |
    anti-CD19 DASH CAR-T